1Cheung AK, Sarnak M, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study[J]. Kidney Intern,2004,65 : 2380 -2389.
2Rocco MV, Yan G, Heyka RJ, et al. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO Study[J]. Am J Nephrol,2001,21:280 -288.
3Cheung AK, Sarnak MJ, Yan G. the Hemodialysis ( HEMO ) Study Group. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients: result of the HEMO study [J]. Kidney Interna, 2000,58:353 - 362.
4Charra B,Chazot C,Jean G,et al. Long 3 x 8 hr dialysis: a three-decade summary [J]. Nephrology ,2003,16 (suppl 7): S64-S69.
5Luik A J, Sande FM, Weideman P, et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodlalysis patiems: a prospective study [J]. Am J Nephrol,2001,21 (6) :471 - 478.
6Fagugli RM, Pasin P, Pasticci F, et al. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study [J]. J Nephrol,2006,19 : 77 - 83.
7Nesrallah GE, Moist LM, Awaraji C, et al. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls [J]. Semin Dial,2004,17(2) :131 - 135.
8Imai E, Fugii M, Kohno, et al. Adenosine A1 receptor antagonist improves intradialytic hypotension [J]. Kidney Int, 2006,69 : 877 -883.
9Brewster UC, Ciampi MA, Abu:Alfa AK, et al. Addition of sertraline to other therapies to reduce dialysis-associated hypotension [J]. Nephrology(Carlton) ,2003,8(6) :296 -301.
